Development Exit Property Finance · Episode 1

HMO Development Finance in 2026: The Licensing Exit

HMO development finance in 2026 exits through Article 4, licensing and an investment valuation, not a quick sale. Exit bridges carry the tenanting window at 0.65 to 0.95 percent a month, up to 70 to 75 percent LTGDV, against a base rate held at 3.75 percent.

70 to 75%

Loan to GDV an exit bridge sizes against a finished, licensed HMO

Indicative published band, developmentexitpropertyfinance.co.uk, mid 2026

0.65 to 0.95%

Monthly rate on an exit bridge over the licensing and tenanting window

Indicative published band, developmentexitpropertyfinance.co.uk, mid 2026

3.75%

Bank of England base rate, held since December 2025

Bank of England

HMO Development Finance in 2026: The Licensing Exit

HMO development finance in 2026 carries a complication that a straightforward residential scheme avoids entirely: the building being finished is only half the job. A house in multiple occupation, whether a large house converted room by room or a former commercial unit turned into a block of let rooms, does not become a lettable, bankable asset the day the works complete. It becomes one when it is licensed by the local authority and tenanted to the rooms the appraisal assumed. The gap between physical completion and a licensed, income-producing HMO is where the exit finance sits, and in the current market that gap is longer and more contested than many developers plan for. This article is commentary on how that position is funded in 2026, not a how-to guide.

The first thing to understand about an HMO exit is that it is gated, not open. A for-sale house can be marketed the moment it is finished. An HMO, by contrast, has to clear two gates before it produces the income it was designed for. The first is planning: in an increasing number of areas an Article 4 direction has removed the permitted development right to convert a single dwelling into a small HMO, so the conversion needs full planning permission rather than a notification, and where that permission is refused or restricted the scheme the developer costed does not exist. The second gate is licensing: a mandatory HMO licence for larger properties, and additional or selective licensing schemes that many councils now operate for smaller ones, each with its own standards on room sizes, amenities, fire safety and management. Neither gate is cleared instantly, and the development loan behind the scheme rarely waits for both.

Before going further, a word on who we are. Development Exit Property Finance is a trading name of Lenzie Consulting Ltd, a broker and introducer, not a lender, and not regulated by the Financial Conduct Authority (FCA); development exit lending sits outside the FCA’s regulated mortgage regime; where a case needs an FCA authorised firm it is referred to one; every figure is an indicative published band, not an offer. We arrange and place these facilities across specialist development exit lenders, bridging lenders and challenger banks, and nothing here is a quote.

The gates that decide the exit

Article 4 and licensing are not paperwork to be dealt with at the end, they are the events the exit turns on, and in 2026 they set the timetable for the money. A converted HMO sitting finished but unlicensed is not yet the asset its valuation assumes, because a lender refinancing it onto HMO term debt wants to see the licence in place, and an investor buying it wants the same certainty. The licensing process runs on the local authority’s clock, not the developer’s, and where an inspection turns up a shortfall against the amenity or fire standards, the works to fix it push the timetable further out. That is time the original development facility was never dated to cover.

The valuation basis makes this sharper still. A finished HMO is not usually valued as bricks and mortar, the way a single house is, but on an investment basis: the value flows from the room rents it produces and the yield an investor would accept for that income. A block of let rooms is worth what its rent roll supports, which means an unlicensed, untenanted HMO is worth materially less than the same building licensed and full, even though not a brick has moved. The whole point of the exit period is to move the property from the bricks-and-mortar figure it commands empty to the investment figure it commands stabilised, and the finance has to survive that journey.

Sizing the bridge on a finished HMO

Once the conversion is physically complete, an exit bridge is sized against the finished HMO on a loan to GDV basis, with the indicative bands published at developmentexitpropertyfinance.co.uk in mid 2026 running up to 70 to 75 percent LTGDV on a strong, fully finished property. Because a licensed, let HMO is valued on its income rather than at conversion cost, that advance frequently tops the development finance being cleared, so the bridge can redeem the construction facility in full and, on a good scheme, release some of the equity locked into the conversion. On an HMO that freed equity is often what recycles into the next conversion while the current one is licensed and filled.

The rate on that bridge sits at 0.65 to 0.95 percent a month over a 6 to 18 month term, and the term is the part an HMO developer should weigh hardest. The licensing and tenanting window on an HMO is rarely quick: the licence application, any remedial works an inspection demands, and then the room-by-room letting all take real time, and a facility dated too tight puts the developer back under redemption pressure before the property is stabilised. Interest is normally retained or rolled up, which suits a property that produces little net income while its rooms are still filling, so nothing is due until the exit lands. Understanding how an exit bridge carries an HMO through licensing and tenanting is mostly a question of dating the term to the real window rather than the optimistic one.

An HMO is not finished when the last room is plastered, it is finished when it is licensed and let, and the exit finance has to cover the distance between the two.

Refinance onto HMO term debt against selling

An HMO developer reaching the end of a conversion has two broad exits, and the choice shapes which finance carries the gap. The first is to refinance the licensed, stabilised HMO onto HMO term debt, holding the property and drawing the room income, which suits a developer building a rental portfolio and wanting to keep the asset. The second is to sell the finished HMO, usually to a portfolio landlord or an investor who buys it as a going concern on its yield, which suits a developer who converts to trade rather than to hold. Both exits need the same thing first: the licence in place and the rooms let, because a term lender and an investment buyer alike price the stabilised income, not the empty shell.

This is where the exit bridge does its work. On either path, the property has to be carried from physical completion to a licensed, tenanted state before the term refinance or the sale can complete, and the construction loan is not the facility to do that carrying. Bridging the property onto an exit facility takes the redemption pressure off, drops the monthly carry to a holding cost, and gives the licensing and letting the time they genuinely need. Where the developer intends to hold, the bridge holds the HMO until the room rents are proven and the property can move onto term debt; where the developer intends to sell, it holds it until a buyer can underwrite a full, licensed block. It is the same logic behind a development exit loan on a completed scheme, applied to an asset whose completion is defined by a licence rather than a snagging list.

What moves an HMO case within the band

Two HMO conversions of the same physical size can price very differently within the 0.65 to 0.95 percent band, and the difference comes down to how clean the exit is. A case where planning is unambiguous, the property sits outside an Article 4 restriction or has full permission in hand, the licence is applied for and the amenity standards are clearly met, and the room rents are evidenced by comparable lettings nearby, is an easy case that lands toward the sharper end of the band. A case where the Article 4 position is contested, the licensing standards are borderline, or the room rents are projected rather than proven, is a harder case that a lender prices more cautiously, because the stabilised value the bridge is sized against is less certain.

The other factor is the exit itself. A developer with a term-refinance route lined up, or a credible buyer for the finished HMO, presents a far stronger case than one whose exit is still notional, because the single thing an exit lender scrutinises hardest is not the borrower but the repayment route. Against a base rate held at 3.75 percent since December 2025, HMO term-refinance pricing has been steady enough that a stabilised block can be underwritten with some confidence, which helps the hold-and-refinance exit stack up in the current market. The same steadier backdrop supports adjacent conversion work, whether an office to residential scheme or a build to rent block, where the exit is likewise a refinance or an investment sale rather than a quick resale. The developers who place an HMO exit bridge easily in 2026 are the ones who treat the licence and the rent roll as the real deliverables, not the plaster.

HMO mortgages and the fees on the exit

The exit debt behind a licensed HMO is usually a set of HMO mortgages, and their criteria shape the bridge that comes before them. An HMO mortgage, whether a specialist buy-to-let product for a smaller house in multiple occupation or a commercial investment mortgage for a larger block, is underwritten on the room income and the licence, so a term lender wants the same things a buyer wants: the HMO licence granted, the rooms let, and the rents evidenced. A developer intending to hold refinances the finished HMO property onto one of these HMO mortgages once it is stabilised, and the exit bridge simply carries the property to the point that mortgage can complete.

The fees are worth setting out plainly, because they affect the net advance on both the bridge and the eventual mortgage. Exit bridges and bridging loans over an HMO carry an arrangement fee, a valuation fee on the finished property, legal fees on both sides, and often an exit fee, and an HMO mortgage adds its own arrangement and valuation fees on completion. As a broker we set out those fees in writing up front and place both legs, the bridging loans that hold the HMO property through licensing and the commercial or buy-to-let HMO mortgages that take it out, so the developer sees the whole cost of the exit rather than only the headline rate. An HMO property that is licensed, let and cleanly evidenced is one a term lender competes for, and the fees and the mortgage terms both improve when the case is that clean.

The twelve-month view

The HMO exit in 2026 is a licensing and letting problem funded properly. A conversion does not become bankable or saleable the day it is finished; it becomes so when the licence is granted and the rooms are full, and the months of process in between have to be carried at a cost that does not consume the margin the conversion was meant to earn. Exit bridges on the published bands are the instrument that buys those months, redeeming the construction facility, dropping the carry, and dating the term around the real licensing and tenanting window rather than an optimistic construction deadline.

For a developer weighing HMO development finance this year, the message is to plan the exit around the two gates that actually control it. Know the Article 4 position before the conversion starts, treat the licensing standards as design requirements rather than afterthoughts, evidence the room rents the way an investment valuer will, and put a bridge in place that lasts long enough for the licence and the lettings to complete. The HMO developers who exit well in 2026 are not the ones with the fastest builds, they are the ones whose licensed, tenanted numbers still stand up when a term lender or a buyer prices the finished block.

HMO funding, bridging finance and the costs

The funding behind an HMO conversion runs in stages, and a developer should hold the whole cost picture in view. Development finance or bridging finance funds the conversion works, an exit bridge carries the licensing and letting window, and specialist HMO mortgages provide the term exit. Each stage of funding carries its own costs: the bridging finance has arrangement and exit fees, the exit bridge its own fees, and the HMO mortgages their arrangement and valuation costs on completion. A developer who maps those costs across the whole funding chain, rather than looking at one rate in isolation, knows the true cost of getting an HMO from a tired building to a licensed, let, refinanced asset.

The exit strategy ties the funding together. A clear exit strategy, whether a refinance onto specialist HMO mortgages or a sale to an investor, tells every lender in the chain how its facility gets repaid, and it is the first thing a specialist HMO lender tests. As a broker we place the bridging finance, the exit bridge and the HMO mortgages against a single exit strategy, so the funding and its costs are planned as one. An HMO with a defined exit strategy and its costs understood is a far easier property to fund than one where the licensing, the mortgages and the eventual exit are treated as separate problems.

FAQ

Why can’t I just sell or refinance an HMO the moment the conversion is finished? Because a finished HMO is not yet the asset its valuation assumes until it is licensed and let. A term lender refinancing it wants the HMO licence in place, and an investment buyer wants the same certainty plus a proven rent roll, since both price the stabilised income rather than the empty shell. The licensing runs on the council’s timetable and the letting fills room by room, so there is a real gap between physical completion and a bankable, saleable property. An exit bridge carries the property across that gap. Every figure here is an indicative published band, not an offer.

How does Article 4 affect an HMO scheme? An Article 4 direction removes the permitted development right to convert a single dwelling into a small HMO in the area it covers, so the conversion needs full planning permission rather than a simple notification. Where that permission is restricted or refused, the scheme the developer costed may not be deliverable, which is a planning risk that sits ahead of any finance. It is one of the two gates, alongside licensing, that decide when and whether an HMO reaches its exit, so the Article 4 position is worth settling before the conversion begins.

On what basis is a finished HMO valued? Usually on an investment basis rather than as bricks and mortar. The value flows from the room rents the property produces and the yield an investor would accept for that income, so a licensed, fully let HMO is worth materially more than the same building empty and unlicensed, even with no physical difference between them. That is why the exit period matters: it moves the property from the empty figure to the stabilised investment figure, and the exit bridge is sized against the finished, income-producing value on a loan to GDV basis up to 70 to 75 percent.

Should I refinance the HMO or sell it? It depends on whether you convert to hold or to trade. Refinancing onto HMO term debt keeps the property and the room income, which suits a developer building a portfolio; selling to a portfolio landlord or investor realises the profit in one transaction, which suits a developer who converts to trade. Either way the property has to be licensed and let first, because both a term lender and a buyer price the stabilised income. The exit bridge carries the HMO to that stabilised state so whichever exit you choose can complete cleanly.

Talk to us

If you have a finished or nearly finished HMO that needs carrying through licensing and letting to a term refinance or a sale, the sooner the licensing position and the room rents are looked at, the more room there is to place the bridge well. You can read more about HMO development finance and start a conversation about how a scheme might be funded.

All figures in this article are indicative published bands for UK property development in 2026, not an offer, a quote or a financial promotion, and any facility is subject to lender terms, valuation and full due diligence. This article was written by Matt Lenzie.

Across the Development Exit Property Finance network

An HMO is not finished when the last room is plastered, it is finished when it is licensed and let, and the exit finance has to cover the distance between the two.

Indicative UK HMO exit finance in 2026

As of July 2026
ItemIndicative published band
Exit bridge rate0.65 to 0.95% per month
Loan to GDV on a finished HMO70 to 75% LTGDV
Term covering licensing and tenanting6 to 18 months
Interest treatmentUsually retained or rolled up
Exit routeRefinance onto HMO term debt or investment sale
Base rate backdrop3.75%, held since December 2025

Listen anywhere

Development Exit Property Finance: 2026 Market Outlook | From Practical Completion to the Last Unit Sold

In this series

More from the Development Exit Property Finance